| 1 | cookie is set by | | | | | | | 7 | 0.47% |
| 2 | the user consent for | | | | | | | 6 | 0.40% |
| 3 | cookies in the category | | | | | | | 5 | 0.33% |
| 4 | the cookies in the | | | | | | | 5 | 0.33% |
| 5 | is used to store | | | | | | | 5 | 0.33% |
| 6 | for the treatment of | | | | | | | 5 | 0.33% |
| 7 | 11 months this cookie | | | | | | | 4 | 0.27% |
| 8 | months this cookie is | | | | | | | 4 | 0.27% |
| 9 | this cookie is set | | | | | | | 4 | 0.27% |
| 10 | user consent for the | | | | | | | 4 | 0.27% |
| 11 | is set by gdpr | | | | | | | 4 | 0.27% |
| 12 | by gdpr cookie consent | | | | | | | 4 | 0.27% |
| 13 | cookie consent plugin the | | | | | | | 4 | 0.27% |
| 14 | consent plugin the cookie | | | | | | | 4 | 0.27% |
| 15 | used to store the | | | | | | | 4 | 0.27% |
| 16 | to store the user | | | | | | | 4 | 0.27% |
| 17 | consent for the cookies | | | | | | | 4 | 0.27% |
| 18 | for the cookies in | | | | | | | 4 | 0.27% |
| 19 | with significant unmet medical | | | | | | | 3 | 0.20% |
| 20 | set by gdpr cookie | | | | | | | 3 | 0.20% |
| 21 | significant unmet medical need | | | | | | | 3 | 0.20% |
| 22 | oral small molecule therapies | | | | | | | 3 | 0.20% |
| 23 | record the user consent | | | | | | | 3 | 0.20% |
| 24 | to record the user | | | | | | | 3 | 0.20% |
| 25 | store the user consent | | | | | | | 3 | 0.20% |
| 26 | cookie is used by | | | | | | | 3 | 0.20% |
| 27 | session no description available | | | | | | | 3 | 0.20% |
| 28 | gdpr cookie consent plugin | | | | | | | 3 | 0.20% |
| 29 | cookie is used to | | | | | | | 3 | 0.20% |
| 30 | and no worsening of | | | | | | | 3 | 0.20% |
| 31 | the video preferences of | | | | | | | 2 | 0.13% |
| 32 | by the gdpr cookie | | | | | | | 2 | 0.13% |
| 33 | the areas of fibrosis | | | | | | | 2 | 0.13% |
| 34 | patients with significant unmet | | | | | | | 2 | 0.13% |
| 35 | to the use of | | | | | | | 2 | 0.13% |
| 36 | lysosomal storage disorders and | | | | | | | 2 | 0.13% |
| 37 | storage disorders and oncology | | | | | | | 2 | 0.13% |
| 38 | unmet medical need in | | | | | | | 2 | 0.13% |
| 39 | development of oral small | | | | | | | 2 | 0.13% |
| 40 | store the video preferences | | | | | | | 2 | 0.13% |